PharmEasy 慶祝在印度簡化醫療保健服務滿 11 週年

PharmEasy's 11-year journey signifies sustained growth and market penetration in India's rapidly evolving digital healthcare landscape.

2026年3月11日
2 min read
PharmEasy LinkedIn
發現輸入
India
完整分析85%
LinkedInX
核心变化

Company anniversary marking 11 years of operations and growth.

Source Report

印度在线医疗聚合商 PharmEasy 正在庆祝其成立 11 周年。自 2015 年成立以来,该公司一直致力于使医疗保健服务更易于获得且价格合理。它在印度 1000 多个城市提供按需送药上门服务,包括处方药、诊断测试和非处方药。这一里程碑标志着他们持续致力于印度医疗保健市场的创新和服务扩展。

Sigvera Intelligence
1PharmEasy marks 11 years of operation in India.
2Company emphasizes accessibility and affordability in healthcare.
3Celebration includes a 'Birthday Bash Sale' for users.
Market Impact

PharmEasy's 11-year journey signifies sustained growth and market penetration in India's rapidly evolving digital healthcare landscape. This longevity demonstrates resilience and a deep understanding of consumer needs, reinforcing its position as a leading aggregator. The company's continued focus on accessibility and affordability is crucial for addressing healthcare gaps in a large, diverse population, potentially influencing broader industry trends and investment in the APAC region's health-tech sector.

区域角度

PharmEasy is a prominent player in the Indian digital health market, a key growth area within APAC. Its sustained operations and expansion highlight the potential and maturity of health-tech solutions in emerging economies, offering a model for other regional players and attracting further investment into the sector.

健康科技与生物技术

Where this signal fits in the broader landscape.

其他
查看全部
Discovered via monitoring
PublisherPharmEasy LinkedIn
發佈日期Mar 11, 2026
來源類型Linkedin
來源分類Discovery Source
信号时间线
首次报道Mar 11, 2026
索引时间Mar 11, 2026
发布时间Mar 11, 2026

https://www.linkedin.com/posts/pharmeasy_takeiteasy-pharmeasy-milestone-activity-7436681766469275648-h5_U

Read Full Source
置信度:75%
Get cross-language signal intelligence

Get curated intelligence delivered to your inbox. No spam, unsubscribe anytime.

Sign in to save notes on signals.

登录
行业健康科技与生物技术地区India事件其他来源发现

Stay ahead of the next signal.

Free weekly briefings with structured signal summaries. No spam, cancel anytime.